Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTungsten west Regulatory News (TUN)

Share Price Information for Tungsten west (TUN)

Share Price is delayed by 15 minutes
Get Live Data
38.75    -0.55 (-1.40%)
Bid:
38.50
Ask:
39.00
Spread: 0.50 (1.299%)
Market Cap: £483.47m
TUN Live PriceLast checked at - London Stock Exchange

Intraday Tungsten west Share Chart

Convertible Loan Note Conversion

2 Jan 2026 07:00

RNS Number : 4023N
Tungsten West PLC
02 January 2026
 

2 January 2026

Tungsten West Plc

 

("Tungsten West" or the "Company")

 

Convertible Loan Note Conversion

 

Further to the Company's announcement of 9 December 2025, Tungsten West (AIM:TUN), the mining company focussed on restarting production at the Hemerdon tungsten and tin mine ("Hemerdon" or the "Project") in Devon in the UK, is pleased to confirm that, on 31 December 2025, the Company completed a partial conversion of the 2023 Convertible Loan Notes (as amended and restated on 1 July 2025) (the "Notes") ("Conversion") at a price of 3 pence per ordinary share of 1 pence each in the capital of the Company ("Ordinary Shares"), issuing 584,831,728 new Ordinary Shares to Noteholders (the "Conversion Shares").

As set out in the Company's announcement of 9 December 2025, any conversion of the Notes that would result in an obligation under Rule 9 of the City Code on Takeovers and Mergers (the "Code") is prohibited without written consent from the relevant noteholder(s), and a Rule 9 waiver in respect of the Notes is not available in the circumstances, therefore the Company has restricted the number of new Ordinary Shares issued to Lansdowne Partners (UK) Ltd ("Lansdowne") and to the two key members of the Drakewood Concert Party (as described in more detail below), such that each holds approximately 29.90% of the Company's issued share capital immediately following the Conversion.

Accordingly, following the Conversion, there remains a total of £12.9 million Notes outstanding including accrued interest to 31 December 2025, held by Lansdowne (£8.7 million), Drakewood Investments Limited (£1.9 million) and Henry Maxey (£2.2 million) (the "Outstanding Notes"). The parties have agreed that the Outstanding Notes will remain outstanding but accrue no further interest (subject to a long stop of 31 March 2026) and be settled via the issue of a separate non-voting class of B-Shares, subject to shareholder approval of this new class of capital at a forthcoming general meeting, as previously announced.

A further announcement will be made in due course to confirm the date and time of the general meeting.

Resultant shareholdings of Lansdowne and the Drakewood Concert Party

The Drakewood Concert Party comprises Drakewood Investments Limited, David Lilley, Henry Maxey, Godolphin Minerals Limited, Mark Thompson and Andrew Monk. Following the issuance of the Conversion Shares the shareholdings of Lansdowne and the individual members of the Drakewood Concert Party will be as follows:

Shareholder

Ordinary Shares held prior to Conversion

Conversion Shares issued

Resultant holding of Ordinary Shares

% of total voting rights

Lansdowne Partners (UK) Ltd

16,666,666

215,124,185

231,790,851

29.90%

Drakewood Concert Party

23,537,619

208,253,231

231,790,850

29.90%

Drakewood Investments Limited / David Lilley

6,506,382

84,438,895

90,945,277

11.73%

Henry Maxey

13,782,089

100,196,491

113,978,580

14.70%

Godolphin Minerals Limited

-

18,310,502

18,310,502

2.36%

Mark Thompson

3,249,148

3,662,100

6,911,248

0.89%

Andrew Monk

-

1,645,243

1,645,243

0.21%

 

Admission of Conversion Shares

The 584,831,728 Conversion Shares will rank pari passu with the existing Ordinary Shares and application will be made for the new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings in the new Ordinary Shares will commence at 8.00 a.m. on or around 6 January 2026.

 

Total Voting Rights

Upon Admission, the Company's issued ordinary share capital will consist of 775,220,231 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury, therefore the total number of Ordinary Shares and voting rights in the Company on Admission will be 775,220,231. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Enquiries

 

Tungsten West

 

Jeff Court

 

Tel: +44 (0) 1752 278500

 

Phil Povey

 

Tel: +44 (0) 1752 278500

 

Strand Hanson

 

(Nominated Adviser and Financial Adviser)

 

James Spinney / James Dance / Abigail Wennington

 

Tel: +44 (0) 207 409 3494

 

BlytheRay

 

(Financial PR)

 

Tim Blythe / Megan Ray

 

Tel: +44(0) 20 7138 3204

 

Email: tungstenwest@blytheray.com

 

Hannam & Partners

 

(Financial Adviser and Broker)

 

Andrew Chubb / Matt Hasson / Jay Ashfield

 

+44 (0)20 7907 8500

 

 

Follow us on X @TungstenWest

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CONEAPFFESDKEFA
Date   Source Headline
7th Nov 20257:00 amRNSSuccessful Processing Trial
29th Sep 20256:20 pmRNSResults of Annual General Meeting
25th Sep 20257:00 amRNSNotice of Annual General Meeting
23rd Sep 20257:00 amRNSBoard Change
4th Sep 20253:02 pmRNS-RInvestor Presentation and Q&A
4th Sep 20257:00 amRNSFinancial Results for the Year Ended 31 March 2025
3rd Sep 20254:30 pmRNSTR-1: Notification of major holdings
28th Aug 20257:00 amRNSLoI from Export-Import Bank of the United States
5th Aug 20257:00 amRNSCompletion of Updated Feasibility Study
18th Jul 20252:50 pmRNSTR-1: Notification of major holdings
2nd Jul 20253:00 pmRNSConvertible Loan Note Update
16th Jun 20259:35 amRNS-RCorporate Presentation
10th Jun 202512:22 pmRNSTR1: Notification of major holdings
10th Jun 20257:00 amRNSDirector Dealings
5th Jun 20257:00 amRNSHemerdon designated a Strategic Project under CRMA
30th May 20257:00 amRNSDevelopment and Economic Plan for Hemerdon
28th May 20258:58 amRNSChange of Registered Address
8th May 20257:00 amRNSConvertible Loan Note Update
13th Jan 20251:20 pmRNSConvertible Loan Note Update
31st Dec 202412:41 pmRNSHalf Year Results
4th Dec 20247:00 amRNSAppointment of Chairman
3rd Dec 20244:05 pmRNSResults of Annual General Meeting
8th Nov 20243:19 pmRNSAmendment to Notice of AGM
1st Nov 20241:02 pmRNSNotice of Annual General Meeting
17th Oct 202412:40 pmRNSConvertible Loan Note Update
8th Oct 20247:00 amRNSDirectorate Change
2nd Oct 202412:00 pmRNSFinancial Results & Lifting of Trading Suspension
2nd Oct 202412:00 pmRNSRestoration - Tungsten West PLC
1st Oct 202410:08 amRNSTemporary Suspension of Trading on AIM
1st Oct 20247:30 amRNSSuspension - Tungsten West plc
15th Aug 20247:00 amRNSAppointment of Chief Executive Officer
23rd Jul 20247:00 amRNSConvertible Loan Note Update
3rd Jul 20247:00 amRNSBoard Changes
12th Jun 20247:00 amRNSMineral Processing Facility Permit Awarded
5th Jun 20247:00 amRNSBoard Change
20th May 20247:00 amRNSExercise of Options
8th May 20244:03 pmRNSExtension of EA public consultation period
28th Mar 20247:00 amRNSConvertible Loan Note Update
25th Mar 20242:00 pmRNSCommencement of EA public consultation period
7th Feb 20247:00 amRNSTR-1: Notification of major holdings
5th Feb 20247:00 amRNSReceipt of Draft Permit for MPF
22nd Dec 20237:00 amRNSHalf Year Results
18th Dec 20237:00 amRNSConvertible Loan Note Update
10th Nov 20237:00 amRNSAppointment of Chief Financial Officer
10th Oct 20234:45 pmRNSResults of Annual General Meeting
15th Sep 20233:45 pmRNSNotice of AGM
14th Sep 20237:00 amRNSFinal Results for the year ended 31 March 2023
4th Sep 202310:28 amRNSAppointment of Non-Executive Directors
16th Aug 20237:00 amRNSProject Update
16th Aug 20237:00 amRNSDirectorate and Management Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.